Veterinary Cardiology Market Report 2025

This veterinary cardiology market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The veterinary cardiology market size has grown strongly in recent years. It will grow from $2.84 billion in 2024 to $3.1 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increasing pet ownership, growing awareness of pet health, rising prevalence of cardiac disorders in animals, expansion of veterinary specialty clinics, and the increasing availability and affordability of pet insurance.

The veterinary cardiology market size is expected to see strong growth in the next few years. It will grow to $4.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing investment in veterinary cardiology research, expansion of telemedicine services for remote consultations, growth in pet adoption rates, rising consumer demand for specialized veterinary care, and the increasing availability of advanced veterinary cardiology training programs. Major trends in the forecast period include cloud security solutions, integrated collaboration platforms, enhanced focus on data privacy and compliance, accelerated migration to multi-cloud environments, and the development of more scalable and flexible cloud infrastructure solutions.

The increasing incidence of heart diseases in both pets and livestock is anticipated to drive growth in the veterinary cardiology market in the future. These heart conditions in animals impact the heart's structure and functionality, resulting in compromised blood circulation, diminished cardiac efficiency, and possible health complications. Contributing factors to the rise in heart diseases among pets and livestock include longer lifespans, obesity, poor nutrition, genetic factors, and insufficient routine veterinary care. Moreover, environmental stressors and changes in living conditions may also heighten the occurrence of cardiovascular diseases in these animals. Veterinary cardiology plays a crucial role in diagnosing, treating, and managing heart diseases in pets and livestock, utilizing specialized care, advanced imaging techniques, and innovative procedures such as minimally invasive surgeries to enhance heart health and overall quality of life. For example, as reported by the American Veterinary Medical Association in March 2024, Myxomatous mitral valve degeneration (MMVD) is the most common heart disease affecting dogs in North America, accounting for 75% of all canine cardiac conditions. It is noted that 85% of small dogs aged 13 years exhibit signs of a myxomatous mitral valve lesion, although this does not always indicate clinical significance. In MMVD cases, the estimated rate of cardiac-related fatalities in dogs ranges from 40% to 70%. Consequently, the growing prevalence of heart diseases in pets and livestock is set to propel the veterinary cardiology market's expansion.

Leading companies in the veterinary cardiology sector are focusing on technological advancements such as transcatheter edge-to-edge mitral valve repair (TEER) to enhance the treatment of heart diseases, improve surgical outcomes, and provide minimally invasive options for better recovery and quality of life. TEER is a less invasive procedure that addresses mitral valve leakage by using a clamp to improve valve function and reduce heart strain. For instance, in February 2023, Willows Veterinary Centre, a veterinary referral center based in the UK, introduced a novel heart treatment for dogs with myxomatous mitral valve disease (MMVD), the most common heart condition in dogs. This procedure, which is considered a viable alternative to traditional surgery in humans, has shown promising early clinical results in dogs. It involves general anesthesia and a minor chest wall incision, with a needle guided to the heart’s apex using continuous X-rays and transesophageal ultrasound to precisely place a V-clamp across the mitral valve to reduce leakage.

In October 2023, EQT AB, a Swedish investment organization, acquired VetPartners for $940 million. This acquisition aligns with EQT’s strategy to expand its investment in the animal health sector, aiming to enhance veterinary services and meet the growing demand for animal healthcare. VetPartners, based in the UK, is a veterinary group that offers comprehensive cardiology care and services for animals.

Major companies operating in the veterinary cardiology market are Merck & Co. Inc., Medtronic plc, Siemens Healthineers AG, Zoetis Inc., Boehringer Ingelheim Animal Health, Royal Canin, IDEXX Laboratories Inc., Ceva Santé Animale S.A., Fujifilm Healthcare Solutions, Dechra Pharmaceuticals PLC, Vetoquinol S.A., ESAOTE S.p.A., SonoScape Medical Corp., Jurox Pty Limited, Eickemeyer Veterinary Equipment GmbH, VetriScience Laboratories Inc., Bionet America Inc., Scil Animal Care Company, Woodley Equipment Company Ltd., Universal Imaging Corporation, VetBlue Inc., TeleVet.

North America was the largest region in the veterinary cardiology market in 2024. The regions covered in the veterinary cardiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary cardiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Veterinary cardiology is a specialized field of veterinary medicine dedicated to diagnosing and managing heart diseases in animals. This branch ranges from routine examinations to advanced treatments, aiming to enhance pets' quality of life by providing targeted diagnosis and treatment for heart conditions, which leads to better health outcomes and longer lifespans.

The primary product types in veterinary cardiology are pharmaceuticals and diagnostics. Pharmaceuticals refer to the medications used to treat heart conditions in animals, such as managing heart failure, arrhythmias, and other cardiovascular issues. Indications for these medications include congestive heart failure, myocardial disease, arrhythmias, and other heart conditions affecting companion animals and production animals. The end users of these products include veterinary hospitals, clinics, and other related facilities.

The veterinary cardiology market research report is one of a series of new reports that provides veterinary cardiology market statistics, including veterinary cardiology industry global market size, regional shares, competitors with an veterinary cardiology market share, detailed veterinary cardiology market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary cardiology industry. This veterinary cardiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary cardiology market consists of revenues earned by entities by providing services such as educational services, emergency care, telemedicine services, follow-up care, and consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. veterinary cardiology market also includes sales of monitoring devices, treatment products, supportive products, and surgical products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.